Showing 1 - 10 of 1,317
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
Regulation fostering Managed Care alternatives in health insurance is spreading. This work reports on an experiment designed to measure the amounts of compensation asked by the Swiss population (in terms of reduced premiums) for Managed-Care type restrictions in the provision of health care. It...
Persistent link: https://www.econbiz.de/10002746136
Persistent link: https://www.econbiz.de/10011898882
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791
drug prescription and income leading to a suboptimal medication. Therefore, PD is not allowed in most OECD countries. In … prescribing behavior between physician which gain income from prescribing a specific drug and their colleagues which prescribe the … drug but do not sell it. Because the considered drugs are bioequivalent we focus on the economic consequence of PD. We …
Persistent link: https://www.econbiz.de/10003900934
The German health care reform of 1997 provides a natural experiment for evaluating the price sensitivity of demand for physicians' services. As a part of the reform, co-payments for prescription drugs were increased step up to 200%. However, certain groups of people were exempted from the...
Persistent link: https://www.econbiz.de/10001806923
This paper studies the interaction between two dynamic domains, (1) an evolutionary biological system ('the environment') whose behaviour determines the availability of a resource stock, and (2) an industry where access to the resource stock is determined by the outcome of a patent race. The...
Persistent link: https://www.econbiz.de/10011597824
This study investigates the effectiveness of dynamic norm nudges in promoting second-dose HPV vaccinations among trendsetters-parents who initiated the firstdose HPV vaccine for their daughters between 2017-2020. Utilizing administrative data from Bogota's Secretariat of Health in a field...
Persistent link: https://www.econbiz.de/10014540586
This paper sheds light on some unexpected consequences of health insurance regulation that may pose a big challenge to insurers’ risk management. Because mandated uniform contributions to health insurance trigger risk selection efforts risk adjustment (RA) schemes become necessary. A good deal...
Persistent link: https://www.econbiz.de/10003900816
This paper analyzes the effects of the "Nordic Model" of prostitution legislation adopted in Sweden in 1999, according to which buyers only are prosecuted. We focus on various measures of violence, distinguishing between known and unknown perpetrator, indoor and outdoor crimes, and on health...
Persistent link: https://www.econbiz.de/10012132463